Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Traditional versus minimistic intradetrusor botulinum injection for idiopathic overactive bladder
IRCT20210214050354N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, double-blind trial of neuronox and lidocaine in overactive bladder (OAB) (2 arms), sponsored by Iran University of Medical Sciences. Started Feb 2021; status: completed.
02
Drugs
neuronoxlidocaine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on IRCT20210214050354N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210214050354N1.